During the past decade, Richard Smith, MD conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Richard Smith, MD" are "Dense Deposit Disease" (1 trials) and "Lymphatic Malformations" (1 trials). Many other conditions were trialed in "Richard Smith, MD" in a lesser frequency.

Most popular intervention types in "Richard Smith, MD" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "OK432" (1 trials) and "Sulodexide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Richard Smith, MD" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Richard Smith, MD". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Richard Smith, MD, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Richard Smith, MD, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".